Baxter Bros Inc Cara Therapeutics, Inc. Transaction History

Baxter Bros Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 21, 2019	SELL	$18.28 - $26.91 $205,650 - $302,737	-11,250 Closed	0 $0
Q2 2019 Jul 29, 2019	SELL	$17.68 - $21.57 $22,100 - $26,962	-1,250 Reduced 10.0%	11,250 $242,000
Q3 2018 Oct 11, 2018	BUY	$17.57 - $23.95 $219,625 - $299,375	12,500 New	12,500 $299,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $15M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Baxter Bros Inc, based on Form 13F filings with the SEC.

Stay updated on Baxter Bros Inc with notifications on news.